Psychobiological Aspects of Panic Disorder by Mograbi, Daniel C. et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors




the world’s leading publisher of
Open Access books







Aspects of Panic Disorder
Daniel C. Mograbi, Vitor Castro-Gomes,
Elie Cheniaux and J. Landeira-Fernandez
Additional information is available at the end of the chapter
http://dx.doi.org/10.5772/60663
Abstract
Anxiety is  a  useful  warning sign that  helps an individual  face  potential  or  real
danger. At appropriate levels, it serves as a warning for the presence of internal
or external threats, causing a person to be alert and prepare to deal appropriate‐
ly with such situations. Moreover, moderate levels of anxiety can lead to improved
performance in several activities. However, anxiety becomes pathological when its
duration is excessively long or its intensity is extremely high and leads to significant
suffering and distress. In such cases, anxiety is appropriately described as part of
a pathological response, characterizing an anxiety disorder. The historical concept
of  a  unitary  anxiety  disorder  has  been  replaced  by  a  heterogeneous  group  of
psychopathologies  with different  etiologies.  Panic  disorder  is  a  complex anxiety
disorder  that  involves  both  recurrent,  unexpected  panic  attacks,  and  persistent
concern  about  having  additional  attacks.  The  present  chapter  reviews  current
psychobiological perspectives in the etiology and treatment of panic disorder. The
first section describes the current classification of this anxiety disorder.  We then
explore possible neural circuitry associated with panic disorder. Finally, the chapter
addresses current treatment approaches, considering the efficacy of different forms
of psychotherapy and pharmacological treatments.
Keywords: Anxiety, Panic Disorder, Neural Circuitry, Behavioral Therapy, Pharma‐
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1. Introduction
Anxiety is a useful warning sign that helps an individual face potential or real danger. At
appropriate levels, it serves as a warning for the presence of internal or external threats, causing
a person to be alert and prepare to deal appropriately with such situations. Moreover,
moderate levels of anxiety can lead to improved performance in several activities [1]. This
notion was originally suggested by Yerkes and Dodson [2], who described the relationship
between anxiety and performance as an inverted U-shaped curve. According to the Yerkes-
Dodson Law, arousal and anxiety have optimal levels for the execution of different tasks, and
anxiety that is above or below this level is detrimental to performance. As shown in Figure 1,
the level of task difficulty influences this optimal anxiety level to maximize performance. More
difficult tasks demand lower levels of anxiety compared with simpler tasks. Regardless of the
difficulty of the task, however, very high levels of anxiety are always detrimental to perform‐
ance. Clearly, anxiety becomes pathological when its duration or intensity is such that it
prevents the normal range of daily activities, leading to social isolation and difficulties at work.
In such cases, anxiety is appropriately described as part of a pathological response, character‐
izing an anxiety disorder.
Figure 1. Yerkes-Dodson Law that illustrates a possible relationship between anxiety level and task performance ac‐
cording to task difficulty.
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Several indications can characterize an anxiety reaction. They can be typically divided into
physiological reactions (e.g., autonomic activation that leads to sweating, palpitations, nausea,
dizziness, and feeling an empty stomach, among others), behavioral responses (e.g., constant
movement of the hands and feet, trembling, and facial expressions), and conscious feelings
(e.g., the subjective experience of tension or apprehension and hypervigilance). Figure 2
illustrates these three elements associated with anxiety reactions. Although several attempts
have been made to understand and classify these anxiety reactions, it was only with Sigmund
Freud that anxiety disorders acquired a large clinical emphasis, and different pathological
conditions that involve anxiety began to be systematically studied. Freud [3] described several
clearly related disorders, among them anxiety attacks and anxiety neurosis, that are now called
panic attacks and panic disorder, respectively [4].
Figure 2. Three components of anxiety reactions.
The present understanding of anxiety disorders made a departure from an earlier view of a
single unitary construct that ranged in intensity from normal to pathological or neurotic levels.
Anxiolytic agents were the main prescription drugs to treat this unitary disorder. The main
shift toward the current view of anxiety disorder occurred with the discovery that imipramine
had a selective effect in the treatment of panic attacks [5]. Additionally, anxiety disorders differ
from each other in the primary object or specificity of threat. Fear of a circumscribed and well-
defined object or situation is a characteristic of specific phobias, whereas diffuse and chronic
sustained anxiety is the main feature of generalized anxiety disorder. Therefore, anxiety
disorders appear to represent a heterogeneous group of psychopathologies with different
etiologies.
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The present chapter reviews current psychobiological perspectives in the etiology and
treatment of panic disorder. The first section below describes the current classification of this
anxiety disorder. We then explore possible neural circuitry associated with panic disorder.
Finally, the chapter addresses current treatment approaches, considering the efficacy of
different forms of psychotherapy and pharmacological treatments.
2. Panic disorder diagnosis
The diagnosis of panic disorder involves two main components. The first component com‐
prises unexpected and recurrent panic attacks. The second component includes constant
worrying over the possibility of new attacks and behavioral changes in response to panic
attacks [6]. Figure 3 presents a scheme of the two symptoms that characterize a panic disorder
diagnosis.
Figure 3. Two main symptoms related to panic disorder diagnosis.
A panic attack is a severe crisis that involves anxiety of great intensity, with an abrupt onset
and short duration. Symptoms include shortness of breath (dyspnea), dizziness, fainting,
palpitations, tremor, sweating, nausea, tingling (paresthesia), hot flashes or chills, and chest
pain. These alterations express a state of autonomic discharge, involving both the sympathetic
and parasympathetic nervous systems. These physiological changes can be accompanied by
depersonalization (feelings of detachment from oneself), de-realization (feelings of unreality),
fear of losing control or going insane, and a sense of impending death. Panic attacks typically
peak quickly and last between 5 and 20 minutes. Because of its signs and symptoms, a panic
attack is often mistaken as a heart attack, which reinforces the sensation of impending death.
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Importantly, panic attacks are not exclusive to panic disorder; they are also present in other
anxiety disorders, such as specific phobias, social phobia, and posttraumatic stress disorder.
In this case, the panic attack is evoked by an object, event, or specific situation. Panic attacks
that characterize panic disorders occur unexpectedly or in an unjustified manner (i.e., they
appear “out of nowhere”). Panic attacks can occur even in situations of high relaxation, such
as during sleep.
Although the recurrence of these panic attacks is a hallmark of panic disorder, the chronic
condition of this anxiety disorder is defined by the constant and persistent fear of experiencing
further attacks or worry about the possible consequences of a panic attack. This chronic form
of anxiety, which is less intense but causes considerable damage to the person because of its
constancy and duration, is quite different from a panic attack.
Patients who suffer from panic disorder may live in a nearly constant state of apprehension.
The frightening prospect of experiencing another panic attack might be so extreme that the
patient develops agoraphobia. This term originally referred to the fear of open spaces or
crowds (from the Greek Ágora). The current concept of agoraphobia is more extensive and
includes avoidance behavior that is caused by places or situations where escape would be
difficult or embarrassing or situations in which help may not be available. The patient avoids
going through tunnels or bridges, riding on a train, subway, or airplane, or being in a crowd
or queue. In more severe cases, the patient refuses to be alone or never leaves home. When the
person is in one of these situations, he might present feelings of intense helplessness. Moreover,
the presence of a trusted companion can change the behavior of these patients. For example,
a person who suffers from agoraphobia can leave the house, make long trips, and perform
virtually almost all daily activities as long as the patient is accompanied by a close relative or
friend.
The recent revision of the Diagnostic and Statistical Manual of Mental Disorders, 5th edition [6]
introduced only minor changes to the classification of panic disorder. The description of panic
attacks was simplified to include expected and unexpected attacks, differentiating between
contextually bound/cued attacks and un-cued attacks. Additionally, panic disorder and
agoraphobia are now considered two different conditions, which can, in some cases, be
comorbid [6].
With regard to epidemiology, the prevalence of panic disorder varies between 1% and 3% in
community samples and between 3% and 8% in clinical samples [7]. The first panic attacks
typically appear during adolescence or early adulthood, and women are up to twice more
likely to develop the disorder than men [7]. The prevalence of panic disorder varies very little
across different regions of the world [8], suggesting an important biological component of the
disorder.
3. Neural circuitry associated with panic disorder
The complex nature of the symptoms that are involved in panic disorders suggests that several
brain regions may be implicated in this pathology. Some of these neural structures and their
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possible connections are presented in Figure 4. One of the main regions involved in panic attack
is the dorsal portion of the periaqueductal gray (dPAG), a phylogenetically older brain
structure that is located in the mesencephalon. Electrical stimulation of the dPAG in humans
can produce symptoms that are very similar to panic attacks, such as feelings of terror and
imminent death, accompanied by increased heart rate and diffuse pain in the face and chest [9].
Figure 4. Flow diagram of the neural circuitry associated with the two main symptoms of panic disorder: panic attack
(top) and anticipatory anxiety (bottom). dPAG, dorsal periaqueductal gray; ACG, anterior cingulate gyrus; MFB, medi‐
al forebrain bundle.
The physiological reactions that are present during a panic attack are likely mediated though
neural circuitries that involve ascending projections from the dPAG to hypothalamic areas.
Results from an awake patient who received bilateral implantation of deep brain stimulation
electrodes in the ventromedial hypothalamic nucleus indicated that stimulation of either
hemisphere of the central area of this hypothalamic nucleus evoked intense panic attack
reactions [10].
One of the main functions of the hypothalamic region is autonomic regulation. The awareness
of these autonomic responses is an extremely important aspect of panic attack. Patients who
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suffer from panic disorder are extremely sensitive to autonomic responses and thus overreac‐
tive to somatic signs [11]. This high sensitivity generates a belief that the autonomic reactions
can have disastrous consequences. For example, a person with high sensitivity to autonomic
reactions might have a greater propensity to interpret such somatic signs as palpitations,
dizziness, nausea, and sweating as signs of a high anxiety reaction, as opposed to someone
else who is less sensitive to these symptoms of anxiety.
This misinterpretation of false autonomic reactions might be attributable to dysfunction in
brain structures that are responsible for interoceptive integration, such as the insular cortex
and the anterior cingulate gyrus [12]. Both of these brain structures are associated with the
cognitive processing of interoceptive information, and problems in the representation of
internal body information might be one of the causes of panic disorder. Indeed, brain imaging
studies indicated that anxiety reactions in patients who suffer from panic disorder recruit
several forebrain areas, such as the insular cortex and anterior cingulate gyrus [13].
Acute autonomic reactions and physiological responses that are triggered by the hypothalamic
area are processed by the insular cortex, which in turn sends projections to the anterior
cingulate gyrus where subjective experiences of these autonomic reactions are generated. The
conscious processing of these intense physiological responses in the absence of a potential or
real external stimulus of danger is a critical issue in the etiology of panic disorder. Considering
the neural circuitry, the symptoms associated with a panic attack are a consequence rather
than the cause of physiological changes in the body. The concept of becoming conscious of an
emotion as a consequence of autonomic changes is consistent with a classic theory that was
independently proposed by William James [14] and Carl Lange [15].
The occurrence of several panic attacks can lead to the development of panic disorder, whose
main characteristic, in addition to the presence of panic attacks, is apprehension and persistent
concern about the possibility of having new panic attacks. This aspect of panic disorder is likely
mediated by ascending projections from the dPAG to amygdaloid complex through the medial
forebrain bundle. The amygdaloid complex is located in the medial temporal lobe of both
hemispheres and can be subdivided into at least 12 nuclei, each associated with different
aspects of an emotional experience. Two of these nuclei are particularly important. The lateral
nucleus is the input pathway and responsible for processing external environmental stimuli.
The central nucleus is the main output of this complex neural circuitry.
As mentioned above, agoraphobia is one of the main conditions that can develop together with
panic disorder. This association between agoraphobia and panic disorder is likely attributable
to the fact that the amygdaloid complex is intimately involved in associative aversive leaning.
The convergence of environmental neutral stimuli with aversive information, triggered by
ascending projections from the dPAG to the lateral nucleus of the amygdala, might result in a
constant state of anticipatory anxiety.
Increasing the sensitivity of the lateral nucleus of the amygdala can make the patient more
reactive to environmental stimuli, causing him to react defensively to situations that other
people simply ignore. In this case, the central nucleus of the amygdala responds adequately
to overactivity of the lateral nucleus of the amygdala. Another possibility might be that the
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lateral nucleus of the amygdala is functioning properly, but the central nucleus of the amyg‐
dala, in the absence of any real danger, has excessively high activity. Understanding this
neuronal circuitry that involves both internal and external stimulus processing and interpre‐
tation is extremely useful for psychotherapeutic interventions to treat panic disorder.
4. Psychological and pharmacological interventions
There are basically two mains strategies to manage the symptoms of panic disorder: psycho‐
therapeutic and pharmacological interventions. Figure 5 illustrates these two types of inter‐
ventions. Most of the psychotherapeutic techniques that are used for the treatment of panic
disorder involve a process of reflection by the patient regarding his emotional dysfunction.
Cognitive behavioral therapy, for example, seeks to change the thought patterns and beliefs
that these patients have while experiencing symptoms of anxiety. An important issue con‐
cerning psychotherapeutic interventions for panic disorder is to change patterns of thinking
to appropriately deal with the physiological reactions that the patient has during the panic
attack. This technique consists of producing, under controlled conditions, some of the
physiological symptoms associated with panic attack so that immediate thinking reactions,
such as “I will die, ” can be replaced by more appropriate interpretations, such as “I am
experiencing great physiological arousal, but it will pass” [16]. The purpose of this technique
is to make the patient reinterpret these physiological reactions by changing their patterns of
catastrophic thinking (or “catastrophizing”) so the patient can adequately deal with these
autonomic reactions [17].
Figure 5. Psychotherapeutic and pharmacological interventions for the treatment of panic disorder. SSRIs, selective se‐
rotonin reuptake inhibitors; MAOIs, monoamine oxidase inhibitors.
Panic attacks hardly manifest exclusively by themselves. Panic attacks are often comorbid with
symptoms of constant worry and anxiety reactions, especially with agoraphobia. Therefore,
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in addition to specific techniques that are related to the treatment of panic attacks, the use of
relaxation training is common for the treatment of the phobic reactions and constant eager
expectation that these patients display.
The effects of psychotherapeutic interventions on the symptoms of panic disorder appear to
be related to cortical structures. These phylogenetically newer structures have the ability to
inhibit the activity of older structures that are related to exacerbated defense reactions that
characterize panic disorder. Indeed, experiments that used animal models of anxiety indicated
that rats require the amygdaloid complex but not cortical areas to acquire a fear response to
an auditory stimulus that was previously associated with an electric shock. However, cortical
regions were necessary for the extinction of fear in response to the auditory stimulus [18].
Recent studies that used two breeding lines of rats that were selected for high and low anxiety-
like behavior [19, 20] indicated that long extinction training was able to extinguish phenotypic
differences between the two lines, but the divergence was restored after just one fear reacqui‐
sition training session [21].
These results allow us to infer that the psychotherapeutic treatment of anxiety disorders does
not change the neural structures that are responsible for the etiology of the disorder but rather
strengthens other structures that are responsible for its inhibition. Supporting this view is the
finding that patients with intense feelings of panic attack exhibited low activity in the pre‐
frontal cortex, thereby causing a lack of inhibition of the amygdaloid complex [22]. Indeed,
patients who were diagnosed with panic disorder and received cognitive behavioral therapy
exhibited a strong association between clinical improvement and a bilateral increase in the
activity of the medial prefrontal cortex [23]. Therefore, a particular anxiety disorder may
remain latent after a good response to psychotherapy but might reappear when this inhibitory
system loses strength, such as in situations where a patient faces new situations of stress.
Anxiolytic drugs have also been used to manage anxiety symptoms in panic disorder. The first
anxiolytic agents that were used to control anxiety were barbiturates, such as phenobarbital,
amobarbital, pentobarbital, and secobarbital, which began to be used to control anxiety in the
early 20th century. Side effects such as drowsiness, sedation, and high dependence potential
prompted the search for other, more effective anxiolytics. In the early 1960s, benzodiazepines
were introduced, such as chlordiazepoxide, diazepam, bromazepam, clobazam, clorazepam,
estazolam, flunitrazepam, flurazepam, lorazepam, and nitrazepam, whose high efficacy
combined with lower toxicity and ability to produce dependence allowed these compounds
to be adopted as the drugs of choice for the treatment of anxiety symptoms.
Recently, drugs with actions on serotonin (5-hydroxytryptamine [5-HT]) neurotransmission
have been used to treat anxiety symptoms. Among these drugs is buspirone, a 5-HT1A
autoreceptor agonist. The stimulation of these receptors leads to a reduction of serotonin
transmission. The therapeutic effect of buspirone takes approximately 2–3 weeks to become
apparent. This period appears to be related to a reduction of serotonergic activity that is caused
by continuous 5-HT1A autoreceptor stimulation. Thus, the therapeutic effects of buspirone
appear to be related to a reduction of serotonergic activity.
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A main issue when dealing with panic disorder is the fact that the occurrence of panic attacks
appears to be resistant to the action of traditional anxiolytic agents. Only high-potency
benzodiazepines, such as alprazolam or clonazepam, when used at high doses, can be
extremely useful for managing anxious features of the acute phase of panic disorder. In such
cases, however, high doses can produce undesirable side effects, such as sleepiness, memory
impairment, and ataxia.
As discussed earlier, the pharmacological treatment of panic disorder has relied on the
pioneering work of Donald Klein, who in the early 1960s showed that imipramine, a tricyclic
antidepressant that inhibits the reuptake of norepinephrine and serotonin, alleviated the
occurrence of panic attacks [5]. Tricyclic antidepressants, such as amitriptyline, clomipramine,
and nortriptyline, were the first drugs that were used in the treatment of panic disorder.
Subsequently, older antidepressants that inhibit monoamine oxidase (MAOIs), such as
phenelzine nialamide, tranylcypromine, and isocarboxazid, were also effective in the treat‐
ment of panic disorder [24]. Currently, selective serotonin reuptake inhibitors (SSRIs), such as
fluoxetine, paroxetine, and sertraline, are employed in the treatment of panic disorder. SSRIs
have the common ability to inhibit the protein that is responsible for transporting serotonin
back into the presynaptic neuron, thereby increasing the activity of this neurotransmitter in
the synaptic cleft.
Notably, the use of SSRIs in the treatment of panic attack paradoxically increases symptoms
of anxiety mainly during the beginning of the treatment. This paradox has been clarified
through a theory developed by the Brazilian neuroscientist Frederick Graeff and British
psychiatrist William Deakin. According to this theory [25], the stimulation of serotonergic
receptors in the amygdala enhances the sensitivity of individuals to dangerous stimuli, thereby
producing an anxiogenic effect. Thus, serotonergic antagonists, such as buspirone, tend to
reduce anxiety. The stimulation of serotonergic systems in the dPAG reduces the occurrence
of panic attacks. In this case, serotonergic agonists have the ability to reduce the occurrence of
panic attacks but with a side effect of increasing the incidence of anxiety reactions through the
action of these compounds in more rostral structures, such as the amygdaloid complex.
Neuroimaging studies have indicated that the anxiety-induced activation of forebrain
structures inhibits the activation of brainstem structures that is caused by panic attacks, and
vice versa [26]. Patients with bilateral amygdala damage were shown to be more prone to panic
attacks than healthy volunteers [27].
Clinical evidence also supports this theory. For example, relaxation therapy that is used for
the treatment of anxiety symptoms can precipitate panic attacks [28]. Furthermore, the
frequency of panic attacks is higher during the initial course of panic disorder, when antici‐
patory anxiety levels are relatively low, than in the late phases of panic disorder, when
anticipatory anxiety is extremely high [29]. Other clinical studies indicated that patients who
suffer from panic disorder and are acutely treated with serotonin releaser and uptake blocker
D-fenfluramine presented a decrease in the occurrence of panic attacks but displayed an
increase in anxiety symptoms [30]. Conversely, clinical trials with the 5-HT2A/2C receptor
antagonist ritanserin reduced symptoms of anticipatory anxiety [31] but exacerbated the
incidence of panic attacks [32]. Finally, experimental studies that used animal models of
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anxiety supported the view that the activation of neural circuitry that is involved in anxiety
might, in fact, inhibit the incidence of panic attacks [33, 34, 35].
5. Concluding remarks
Although anxiety is important in our everyday lives, it becomes a pathological phenomenon
when its duration or intensity is extremely high and leads to significant suffering and distress.
The historical concept of a unitary anxiety disorder has been replaced by a heterogeneous
group of psychopathologies with different etiologies. Panic disorder is a complex anxiety
disorder that involves both recurrent, unexpected panic attacks and persistent concern about
having additional attacks. Several brain structures participate in different components of panic
disorder. The dPAG is a core structure remove involved in the genesis of panic attacks.
Projections to the hypothalamus and then to the insular cortex and anterior cingulate gyrus
through the nucleus of the solitary tract might be responsive for misinterpreting interoceptive
information that is associated with false autonomic reactions. Projections to the amygdaloid
complex might be associated with anticipatory anxiety as a consequence of recurrent panic
attacks. Psychological interventions combine in vivo exposure to interoceptive and autonomic
symptoms that are present during a panic attack with relaxation training to manage the anxiety
associated with having another panic attack. Pharmacological treatment combines high-
potency benzodiazepines and substances with antidepressant properties, suggesting relative
independence between the mechanisms that modulate panic attack and the constant antici‐
patory anxiety associated with new panic attacks. Indeed, clinical and experimental results
with animal models of anxiety suggest that anticipatory anxiety might have an inhibitory effect
on panic attacks.
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